Arthur Kuan - 12 Mar 2026 Form 4 Insider Report for CG Oncology, Inc. (CGON)

Role
Chief Executive Officer, Director
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact for Arthur Kuan
Issuer symbol
CGON
Transactions as of
12 Mar 2026
Net transactions value
$0
Form type
4
Filing time
13 Mar 2026, 16:09:24 UTC
Previous filing
06 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kuan Arthur Chief Executive Officer, Director C/O CG ONCOLOGY, INC., 400 SPECTRUM CENTER DRIVE, SUITE 2040, IRVINE /s/ Joshua F. Patterson, Attorney-in-Fact for Arthur Kuan 13 Mar 2026 0002007101

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGON Common Stock Options Exercise +64,612 +47% $1.72* 200,763 12 Mar 2026 Direct
transaction CGON Common Stock Tax liability -1,847 -0.92% $60.15* 198,916 12 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGON Employee Stock Option (Right to Buy) Options Exercise -64,612 -100% $0.000000* 0 12 Mar 2026 Common Stock 64,612 $1.72 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a "net exercise" of outstanding stock options. The reporting person received 62,765 shares of common stock on net exercise of an option to purchase 64,612 shares of common stock. The Company withheld 1,847 shares of common stock underlying the option and the reporting person paid in cash the delta for payment in full of the aggregate exercise price. This transaction does not represent a sale by the reporting person.
F2 The stock option is currently vested and exercisable.